[EN] THYMOQUINONE ANALOGS FOR THE TREATMENT OF PANCREATIC CANCER<br/>[FR] ANALOGUES DE THYMOQUINONE DANS LE TRAITEMENT DU CANCER DU PANCRÉAS
申请人:UNIV WAYNE STATE
公开号:WO2011126544A2
公开(公告)日:2011-10-13
Analogs of thymoquinone, an active compound extracted from Nigellasativa (black seed oil) are 2,5-bis (alkyl/aryl amino) 1, 4-benzoquinones, are more potent than the naturally-occurring compound (e.g, have a lower IC50) in terms of inhibition of cell growth, induction of apoptosis, and modulation of transcription fact NF-ĸB. Used in conjunction with conventional chemotherapeutic agents, such as gemcitibine or oxaliplatin, the analogs sensitize gemcitabine-resistant pancreatic cancer cells to gemcitabine-induced apoptosis. A preferred compound is 2,5-dichloro- 3,6-bis[3-methoxyphenyl)amino]cyclohexa-2,5,-diene- 1,4-dione.